Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Amyloidosis”

173 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 173 results

Not applicableLooking for participantsNCT06866912
What this trial is testing

Observational Epidemiological Study of Patients Suffering From Systemic Amyloidosis

Who this might be right for
Cardiomyopathy
IRCCS Azienda Ospedaliero-Universitaria di Bologna 750
Testing effectiveness (Phase 2)Study completedNCT05235269
What this trial is testing

Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis

Who this might be right for
Amyloidosis
Attralus, Inc. 33
Testing effectiveness (Phase 2)Study completedNCT00255749
What this trial is testing

Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Jonsson Comprehensive Cancer Center 89
Testing effectiveness (Phase 2)Ended earlyNCT02994784
What this trial is testing

Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients

Who this might be right for
Amyloidosis; Systemic
Boston Medical Center 27
Early research (Phase 1)Ended earlyNCT03000660
What this trial is testing

Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis

Who this might be right for
AL Amyloidosis
Tufts Medical Center 3
Testing effectiveness (Phase 2)WithdrawnNCT05486481
What this trial is testing

Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)

Who this might be right for
AL AmyloidosisLight Chain (AL) AmyloidosisSystemic Light Chain Disease
Alfred Chung, MD
Testing effectiveness (Phase 2)Study completedNCT00005804
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT01789242
What this trial is testing

A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis

Who this might be right for
AmyloidosisSystemic Light Chain Amyloidosis
Criterium, Inc. 32
Very early researchStudy completedNCT00424242
What this trial is testing

Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Northwestern University 15
Large-scale testing (Phase 3)Study completedNCT00661999
What this trial is testing

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Mayo Clinic 502
Testing effectiveness (Phase 2)Study completedNCT01849783
What this trial is testing

Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma

Who this might be right for
Extramedullary PlasmacytomaIsolated Plasmacytoma of BoneLight Chain Deposition Disease+4 more
Margarida Magalhaes-Silverman 41
Testing effectiveness (Phase 2)Ended earlyNCT00075608
What this trial is testing

2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
Boston Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT02908347
What this trial is testing

Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients

Who this might be right for
PsoriasisPlaque Psoriasis
MetrioPharm AG 46
Large-scale testing (Phase 3)Study completedNCT00003687
What this trial is testing

Treatment for Chronic Pain in Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
NCIC Clinical Trials Group 87
Not applicableLooking for participantsNCT06699394
What this trial is testing

Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis

Who this might be right for
AL Amyloidosis
Peking University People's Hospital 20
Not applicableLooking for participantsNCT01137643
What this trial is testing

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
UNC Lineberger Comprehensive Cancer Center 15,000
Early research (Phase 1)Study completedNCT01406314
What this trial is testing

SAP Depleter Dose Assessment Study in Patients

Who this might be right for
Amyloidosis
GlaxoSmithKline 17
Very early researchLooking for participantsNCT07626476
What this trial is testing

Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis

Who this might be right for
Relapsed/Refractory Light Chain AmyloidosisAL AmyloidosisSystemic Light Chain Amyloidosis
Beijing Boren Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00416624
What this trial is testing

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Mayo Clinic 239
Early research (Phase 1)Looking for participantsNCT05978661
What this trial is testing

FKC288 for Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Who this might be right for
Light Chain Amyloidosis
Nanjing University School of Medicine 12
Load More Results